Drug Trial Radar · NCT02536508
Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Last checked: Nov 19, 2026Latest source record: Feb 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
627
Actual
Start
Aug 10, 2015
Primary completion
Sep 12, 2017
Study completion Sep 12, 2017
Sponsor
- Lead sponsor
- Pearl Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 1, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Conditions
- COPD
Interventions
BGF MDI 320/14.4/9.6 μgDrug
Budesonide, Glycopyrronium, and Formoterol Fumarate
GFF MDI 14.4/9.6 μgDrug
Glycopyrronium and Formoterol Fumarate
BFF MDI 320/9.6 μgDrug
Budesonide and Formoterol Fumarate
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in BMD of the Lumbar SpineTime frame: at week 52
- Change From Baseline in the LOCS III (P) Score at Week 52Time frame: at week 52
Locations
64 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Dothan, Alabama
Research Site
Jasper, Alabama
Research Site
Peoria, Arizona
Research Site
Phoenix, Arizona
Research Site
Fullerton, California
Research Site
Gold River, California
Research Site
Poway, California
Research Site
Rolling Hills Estates, California
Research Site
Sacramento, California
Research Site
Clearwater, Florida
Research Site
Miami, Florida
Research Site
Ormond Beach, Florida
Research Site
Pensacola, Florida
Research Site
Tamarac, Florida
Research Site
Tampa, Florida
Research Site
Winter Park, Florida
Research Site
Dacula, Georgia
Research Site
Norcross, Georgia
Research Site
Rincon, Georgia
Research Site
Edina, Minnesota
Research Site
Minneapolis, Minnesota
Research Site
Minneapolis, Minnesota
Research Site
Woodbury, Minnesota
Research Site
Saint Charles, Missouri
Research Site
St Louis, Missouri
Research Site
Las Vegas, Nevada
Research Site
Reno, Nevada
Research Site
Albuquerque, New Mexico
Research Site
Charlotte, North Carolina
Research Site
Gastonia, North Carolina
Research Site
Greensboro, North Carolina
Research Site
Hendersonville, North Carolina
Research Site
Mooresville, North Carolina
Research Site
Wilmington, North Carolina
Research Site
Winston-Salem, North Carolina
Research Site
Cincinnati, Ohio
Research Site
Cincinnati, Ohio
Research Site
Cincinnati, Ohio
Research Site
Columbus, Ohio
Research Site
Columbus, Ohio
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.